ArticleBMC cancer2022

ArTisaN trial protocol: a single Centre, open-label, phase II trial of the safety and efficacy of TheraSphere selective internal radiation therapy (SIRT) in the treatment of inoperable metastatic (liver) neuroendocrine neoplasia (NENs).

Rohini Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.